Open letters

The European Medicines Agency (EMA) publishes open letters, usually in response to contributions and feedback from stakeholders.

Response to the Institute for Quality and Efficiency in Health Care (IQWiG) and the Cochrane Collaboration on transparency of COVID-19-related activities

How useful was this page?

Add your rating